ICG writes €500m cheque for medical single-asset deal

ICG underwrote nearly half the transaction on Curium Pharma, an asset described as 'cream of the crop' by one secondaries buyer.

2 December 2020•2 mins read
healthcare
LinkedInXEmail
LinkedInXEmail

Related articles